Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Atria Wealth Solutions Inc.

Atria Wealth Solutions Inc. trimmed its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 33.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,915 shares of the pharmacy operator’s stock after selling 12,198 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in Walgreens Boots Alliance were worth $223,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. Brooklyn Investment Group lifted its stake in shares of Walgreens Boots Alliance by 21.1% during the fourth quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock worth $44,000 after buying an additional 830 shares during the period. First Financial Corp IN increased its position in shares of Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 885 shares during the period. CWA Asset Management Group LLC increased its position in shares of Walgreens Boots Alliance by 9.2% in the 4th quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock valued at $120,000 after acquiring an additional 1,084 shares during the period. OLD Second National Bank of Aurora raised its stake in Walgreens Boots Alliance by 35.1% in the 3rd quarter. OLD Second National Bank of Aurora now owns 4,562 shares of the pharmacy operator’s stock worth $41,000 after acquiring an additional 1,185 shares during the last quarter. Finally, Sigma Planning Corp lifted its position in Walgreens Boots Alliance by 4.2% during the 3rd quarter. Sigma Planning Corp now owns 31,632 shares of the pharmacy operator’s stock worth $283,000 after acquiring an additional 1,282 shares during the period. 58.59% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have recently weighed in on WBA. Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Royal Bank of Canada increased their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 15th. Bank of America lifted their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and decreased their target price for the company from $11.00 to $9.00 in a research report on Friday. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus price target of $11.54.

Walgreens Boots Alliance Price Performance

NASDAQ:WBA opened at $10.69 on Friday. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $22.05. The stock’s 50-day moving average price is $10.50 and its 200-day moving average price is $9.72. The stock has a market capitalization of $9.23 billion, a PE ratio of -1.04, a price-to-earnings-growth ratio of 1.31 and a beta of 0.65.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. Walgreens Boots Alliance’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period last year, the company earned $0.66 earnings per share. As a group, equities analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.